University of California, San Diego

  Award Total: $9,472,209 # of Awards: 59 Home Page:

Investigators

  Sonia Ancoli-Israel , Ph.D.- Bogi Andersen , M.D.- Sung Hee Baek , Ph.D.- Wayne Bardwell , Ph.D.- Gerry Boss , M.D.- Eliot Bourk , BA- Deborah Cadena , Ph.D.- Yixue Cao , Ph.D., M.D.- Chung-leung Chan , Ph.D.- Helena Chang , M.D., Ph.D.- David Cheresh , Ph.D.- Jay Desgrosellier , Ph.D.- Daniel Donoghue , Ph.D.- Daniel Donoghue , Ph.D.- Lavinia Fiorentino , Ph.D.- Gordon Gill , M.D.- Ananda Goldrath , Ph.D.- Jessica Gorman , M.P.H.- Sheri Hartman , PhD- Thorsten Heinzel , Ph.D.- Kathryn Hollenbach , M.P.H, Ph.D.- Stephen Howell , M.D.- Randall Johnson , Ph.D.- Michael Karin , Ph.D.- Michael Karin , Ph.D.- Thomas Kipps , M.D., Ph.D.- Hillary Klonoff-Cohen , Ph.D.- Hillary Klonoff-Cohen , Ph.D.- Richard Kurten , Ph.D.- George Leopold , M.D.- Zheng-gang Liu , Ph.D.- JianXiang Liu , M.D., Ph.D.- Janine Low-Marchelli , B.S.- Carol MacLeod , Ph.D.- Malcolm Mitchell , M.D.- Malcolm Mitchell , M.D.- Jakob Nebeker , B.S.- Thomas Nelson , M.D.- Thomas Nelson , M.D.- Alexander Nesterov , Ph.D.- Morgan O'Hayre , B.S.- Michelle Rissling , M.S.- Georgia Sadler , Ph.D. M.B.A.- Georgia Sadler , Ph.D. M.B.A.- Georgia Sadler , Ph.D. M.B.A.- Sanjay Adrian Saldanha , Ph.D.- Hungyi Shau , Ph.D.- Konstantin Stoletov , Ph.D.- Irene Su , M.D.- Barbara Susini , Ph.D.- Emmanuel Theodorakis , Ph.D.- Mathias Treier , Ph.D.- Jeff Tsai , Ph.D.- Oksana Tyurina , Ph.D.- David Vera , Ph.D.- David Vera , Ph.D.- Anne Wallace , M.D.- Shizhen Emily Wang , Ph.D.- Noel Warfel , M.S.- Yang Xu , Ph.D.- Jing Yang , Ph.D.- Jing Yang , Ph.D.-

Grants

Title[sort] Cycle Award[sort]
Targeting tumor-initiating niche to overcome chemoresistance 2018 (Cycle 24) $187,500
 Investigator(s): Jing Yang, Ph.D. 24IB-0066
Physical activity intervention for young cancer survivors 2018 (Cycle 24) $108,513
 Investigator(s): Sheri Hartman, PhD 24AB-1300
Preclinical analysis of MAD28 in inflammatory breast cancer 2016 (Cycle 22) $210,715
 Investigator(s): Emmanuel Theodorakis, Ph.D. 22IB-0024
Systemic metabolic reprogramming by BC-secreted microRNAs 2014 (Cycle 20) $52,753
 Investigator(s): Shizhen Emily Wang, Ph.D. 20IB-0118A
Intervening on Reproductive Health in Young BC Survivors 2014 (Cycle 20) $968,782
 Investigator(s): Irene Su, M.D. 20OB-0144
API-Friendly Resources for BC Clinical Trials 2014 (Cycle 20) $43,250
 Investigator(s): Georgia Sadler, Ph.D. M.B.A. 20AB-1300
A first-in-class allosteric RAF inhibitor for breast cancer 2013 (Cycle 19) $187,500
 Investigator(s): David Cheresh, Ph.D. 19IB-0130
Examining Metastatic Potential in Mammary Stem Cells 2012 (Cycle 18) $150,000
 Investigator(s): Jay Desgrosellier, Ph.D. 18IB-0020
The Role of Twist1 in Epithelial-mesenchymal Transition 2010 (Cycle 16) $90,000
 Investigator(s): Jeff Tsai, Ph.D. 16FB-0009
Sound Speed Tomography for Early Breast Cancer Detection 2009 (Cycle 15) $74,325
 Investigator(s): Jakob Nebeker, B.S. 15GB-0023
Health Anxiety as a Risk for Insomnia in Breast Cancer 2009 (Cycle 15) $72,976
 Investigator(s): Michelle Rissling, M.S. 15GB-0024
Novel Akt Regulatory Factor PHLPP in Breast Cancer 2009 (Cycle 15) $0
 Investigator(s): Noel Warfel, M.S. 15GB-0018
Reproductive Concerns and Depression among Younger Survivors 2008 (Cycle 14) $34,617
 Investigator(s): Jessica Gorman, M.P.H. 14GB-0140
Dissecting the Role of Twist in Breast Cancer Metastasis 2008 (Cycle 14) $76,000
 Investigator(s): Janine Low-Marchelli, B.S. 14GB-0144
Chemokine Receptor Signaling in Breast Cancer 2008 (Cycle 14) $74,660
 Investigator(s): Morgan O'Hayre, B.S. 14GB-0147
FGFR2 Signaling in Human Breast Cancer Cells 2008 (Cycle 14) $100,000
 Investigator(s): Daniel Donoghue, Ph.D. 14IB-0065
Breast Cancer Clinical Trials Education Program 2008 (Cycle 14) $158,140
 Investigator(s): Georgia Sadler, Ph.D. M.B.A. 14BB-2600
Science Literacy & Breast Cancer Clinical Trials Education 2007 (Cycle 13) $44,003
 Investigator(s): Georgia Sadler, Ph.D. M.B.A. 13AB-3500
Novel Cytokine Immunotherapy for Breast Cancer 2007 (Cycle 13) $150,000
 Investigator(s): Ananda Goldrath, Ph.D. 13IB-0086
Early Breast Cancer Detection Using 3D Ultrasound Tomography 2007 (Cycle 13) $225,000
 Investigator(s): Thomas Nelson, M.D. 13NB-0176
Inflammation Alters Transcription by ER in Breast Cancer 2006 (Cycle 12) $75,051
 Investigator(s): Eliot Bourk, BA 12GB-0015
Twist Activation in Breast Cancer Metastasis 2006 (Cycle 12) $150,000
 Investigator(s): Jing Yang, Ph.D. 12IB-0065
cAMP Antagonists of Protein Kinase as Breast Cancer Drugs 2005 (Cycle 11) $28,404
 Investigator(s): Sanjay Adrian Saldanha, Ph.D. 11FB-0080A
An Approach to Antiestrogen Resistance in Breast Cancer 2005 (Cycle 11) $132,860
 Investigator(s): Oksana Tyurina, Ph.D. 11FB-0081
Role of Integrins in Lymphangiogenesis During Breast Cancer 2005 (Cycle 11) $134,530
 Investigator(s): Barbara Susini, Ph.D. 11FB-0006
Treating Insomnia with CBT in Women with Breast Cancer 2005 (Cycle 11) $73,218
 Investigator(s): Lavinia Fiorentino, Ph.D. 11GB-0049
Effect of Bright Light on Fatigue in Breast Cancer 2005 (Cycle 11) $141,282
 Investigator(s): Sonia Ancoli-Israel, Ph.D. 11IB-0034
Early Breast Cancer Detection Using 3D Ultrasound Tomography 2005 (Cycle 11) $149,879
 Investigator(s): Thomas Nelson, M.D. 11IB-0035
Imaging RhoC-induced Breast Cancer Invasion and Angiogenesis 2005 (Cycle 11) $119,220
 Investigator(s): Konstantin Stoletov, Ph.D. 11FB-0088A
Hormone, Psychologic & Immunologic Factors & BC Survivorship 2004 (Cycle 10) $286,036
 Investigator(s): Hillary Klonoff-Cohen, Ph.D. 10PB-0012
Potential Role of a Novel Repressor Complex in Breast Cancer 2002 (Cycle VIII) $0
 Investigator(s): JianXiang Liu, M.D., Ph.D. 8FB-0133
Prognostic Value of Ras Activation in Breast Cancer 2002 (Cycle VIII) $498,596
 Investigator(s): Gerry Boss, M.D. 8EB-0105
Prognostic Value of Ras Activation in Breast Cancer 2002 (Cycle VIII) $498,596
 Investigator(s): Anne Wallace, M.D. 8EB-0105
Genetic Aspects of Physiological Response During Lactation 2001 (Cycle VII) $593,000
 Investigator(s): Randall Johnson, Ph.D. 7PB-0108
Role of IKKa in Mammary Gland Development 2001 (Cycle VII) $563,696
 Investigator(s): Michael Karin, Ph.D. 7PB-0071
Women with Breast Cancer: Quality of Life and Diet Adherence 2001 (Cycle VII) $164,427
 Investigator(s): Wayne Bardwell, Ph.D. 7KB-0097
The Role of N-CoR During Normal Mammary Gland Development 2000 (Cycle VI) $75,583
 Investigator(s): Sung Hee Baek, Ph.D. 6FB-0023
A Novel Signal Transduction Pathway in Breast Cancer 2000 (Cycle VI) $79,981
 Investigator(s): Yixue Cao, Ph.D., M.D. 6FB-0039
Nitric Oxide and Arginine in Normal and Tumorous Breast 1999 (Cycle V) $200,000
 Investigator(s): Carol MacLeod, Ph.D. 5JB-0134
The Regulation of p53 Activity in Breast Cancer 1999 (Cycle V) $51,393
 Investigator(s): Yang Xu, Ph.D. 5JB-0056
A New Gene Regulation Factor, LMO-4, in Breast Cancer 1999 (Cycle V) $134,677
 Investigator(s): Bogi Andersen, M.D. 5JB-0119
Breast Cancer Immunotherapy Using CD4+ Lymphocytes 1998 (Cycle IV) $43,289
 Investigator(s): Malcolm Mitchell, M.D. 4CB-0066
Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis 1998 (Cycle IV) $506,070
 Investigator(s): Hillary Klonoff-Cohen, Ph.D. 4EB-5900
Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis 1998 (Cycle IV) $506,070
 Investigator(s): Hungyi Shau, Ph.D. 4EB-5900
Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis 1998 (Cycle IV) $506,070
 Investigator(s): Helena Chang, M.D., Ph.D. 4EB-5900
Sentinel Node Detection via Targeted Fluorescence 1998 (Cycle IV) $41,259
 Investigator(s): David Vera, Ph.D. 4IB-0051
Outpatient Stem Cell Transplants for Breast Cancer 1996 (Cycle II) $189,970
 Investigator(s): Kathryn Hollenbach, M.P.H, Ph.D. 2CB-0121A
T Cell immunotherapy of human breast cancer 1996 (Cycle II) $197,305
 Investigator(s): Malcolm Mitchell, M.D. 2CB-0196
Molecular mechanisms of EGF receptor endocytosis 1996 (Cycle II) $69,685
 Investigator(s): Alexander Nesterov, Ph.D. 2FB-0057
Potential Tumor Suppressors in Breast Cancer 1996 (Cycle II) $69,361
 Investigator(s): Mathias Treier, Ph.D. 2FB-0060
Why Does Normal Cell Death Not Occur in Breast Cancer? 1996 (Cycle II) $38,088
 Investigator(s): Zheng-gang Liu, Ph.D. 2FB-0062
Enhanced lysosomal degradation of growth factor receptors 1996 (Cycle II) $295,246
 Investigator(s): Gordon Gill, M.D. 2RB-0216
A New Radiotracer for Sentinel Node Imaging of Breast Cancer 1996 (Cycle II) $27,183
 Investigator(s): David Vera, Ph.D. 2RB-0118A
Molecular control of breast exposure to selenium 1996 (Cycle II) $124,870
 Investigator(s): Stephen Howell, M.D. 2RB-0125
Growth Factor Control of Breast Tumor Cell Proliferation 1995 (Cycle I) $35,000
 Investigator(s): Richard Kurten, Ph.D. 1FB-0314
EGFR Structure for Drug Design Targeted to Breast Cancer 1995 (Cycle I) $68,730
 Investigator(s): Chung-leung Chan, Ph.D. 1FB-0319
Isolation of Estrogen Receptor Cofactors fron Breast Tumors 1995 (Cycle I) $68,607
 Investigator(s): Thorsten Heinzel, Ph.D. 1FB-0439
Ultrasound Computed Tomography for Breast Lesion Detection 1995 (Cycle I) $45,382
 Investigator(s): George Leopold, M.D. 1IB-0322
ErbB2 and Control of Growth in Breast Cancer Cells 1995 (Cycle I) $144,936
 Investigator(s): Deborah Cadena, Ph.D. 1KB-0140
Regaining Control over Breast Cancer Cells 1995 (Cycle I) $270,132
 Investigator(s): Michael Karin, Ph.D. 1RB-0214
Mechanisms of Aberrant Cell Growth in Breast Cancer 1995 (Cycle I) $276,643
 Investigator(s): Daniel Donoghue, Ph.D. 1RB-0318
Peptide Vaccines for Immunoprevention of Breast Cancer 1995 (Cycle I) $299,886
 Investigator(s): Thomas Kipps, M.D., Ph.D. 1RB-0401